跳至主要内容
临床试验/NCT06298669
NCT06298669终止不适用

Selection of Cardiac Resynchronization Therapy Pacing Modalities in Patients Supported by LVADs

Indiana University2 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2023年8月9日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
1
试验地点
2
主要终点
6 Minute Walk Test Performance

研究概览

简要总结

The study is a randomized, single-blind crossover prospective study in which investigators will determine the clinical outcomes of cardiac resynchronization therapy (CRT) pacing modalities in patients with left ventricular assist devices (LVAD). Only patients are blinded. This is a small-scale study from which future larger scale randomized controls can be performed. The primary endpoint will be the effect of BiV and RV pacing setting on the 6-minute walk test.

详细描述

Heart failure patients with reduced left ventricular systolic function and worsening clinical status are frequently treated with mechanical devices. Cardiac resynchronization therapy (CRT) and left ventricular assist devices (LVAD) are mainstays of advanced heart failure treatment and have independently been demonstrated to decrease mortality. However, minimal research documents the utility of these two modalities in unison. There have been recent investigations comparing Biventricular (BiV) versus right ventricular (RV) pacing suggesting better exercise performance and decreased left ventricular (LV) volumes with RV pacing. This discovery contrasts with prior meta-analysis that reports no difference between LVAD patients with and without CRT including mortality and hospitalizations. Investigators aim to compare BiV pacing and RV pacing in LVAD patients with CRT on patient's exercise tolerance and frequency of tachyarrhythmias. Additionally, research is required to form a conclusion on the role of CRT in LVAD patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with both an LVAD and CRT device with functional leads
  • Age 18 years and older
  • Ability to walk
  • Ability to sign consent

排除标准

  • Patients with permanent atrial fibrillation
  • Patients who are pacemaker dependent
  • Patients with sustained ventricular tachycardia

结局指标

主要结局

6 Minute Walk Test Performance

时间窗: Baseline visit; Three-month visit

The distance walked over 6 minutes was measured at the baseline visit and the visit three months after baseline. The six month visit did not occur because the study was terminated.

次要结局

  • EQ-5D-3L Quality of Life Score(Baseline visit)
  • Serum NT-PRO-BNP(Baseline visit; Three-month visit)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Maya Guglin

Professor of Clinical Medicine

Indiana University

研究点 (2)

Loading locations...

相似试验